Table 2.

Percentage (%) resistance of bacteria to antibiotics in different WWTPs.

Antibiotic	WWTP	% Resistance of THB to antibiotic in the influent	% Resistance of THB to antibiotic in the effluent	% Resistance of E. coli to antibiotic in the influent	% Resistance of E. coli to antibiotic in the effluent	References
Erythromycin	WWTP14	2.5	4.8			Ateba et al., 2020
	WWTP15	5.4	3.1			Ateba et al., 2020
Ciprofloxacin (CIP)	WWTP14	2.5	1.6			Ateba et al., 2020
	WWTP15	2.6	1.6			Ateba et al., 2020
	NWWTP			17	23	Pillay and Olanirano, 2016
	NGTW			25	40	Pillay and Olanirano, 2016
Trimethoprim/sulfamethoxazole (STX)	WWTP9			70	90	Gumede et al., 2021
	WWTP10			60	100	Gumede et al., 2021
	WWTP11			40	90	Gumede et al., 2021
	WWTP12			90	90	Gumede et al., 2021
Trimethoprim	WWTP14	42.5	73			Ateba et al., 2020
	WWTP15	50	46.9			Ateba et al., 2020
Tetracycline (TET)	WWTP9			30	80	Gumede et al., 2021
	WWTP10			60	100	Gumede et al., 2021
	WWTP11			20	100	Gumede et al., 2021
	WWTP12			80	90	Gumede et al., 2021
	NWWTP			63	86	Gumede et al., 2021
	NGTW			41	68	Gumede et al., 2021
	WWTP14	10	16.1			Ateba et al., 2020
	WWTP15	40.5	17.2			Ateba et al., 2020
Penicilin	WWTP13			70	100	Ateba et al., 2020
	WWTP14	42.9	58.8			Ateba et al., 2020
	WWTP15	70.4	39.5			Ateba et al., 2020
Ampicillin	WWTP6	19	3			Turolla et al., 2018
	WWTP7	25	14			Turolla et al., 2018
	WWTP8	16	23			Turolla et al., 2018
	WWTP9			90	90	Gumede et al., 2021
	WWTP10			90	100	Gumede et al., 2021
	WWTP11			80	100	Gumede et al., 2021
	WWTP12			100	100	Gumede et al., 2021
	NWWTP			80	57	Pillay and Olanirano, 2016
	NGTW			53	60	Pillay and Olanirano, 2016
	WWTP13			0	40	Nzima et al., 2020
	WWTP14	53.6	61			Nzima et al., 2020
	WWTP15	92.6	55.8			Nzima et al., 2020